Cargando…
Rare POLN mutations confer risk for familial nasopharyngeal carcinoma through weakened Epstein-Barr virus lytic replication
BACKGROUND: Nasopharyngeal carcinoma (NPC) exhibits significant familial aggregation; however, its susceptibility genes are largely unknown. Thus, this study aimed to identify germline mutations that might contribute to the risk of familial NPC, and explore their biological functions. METHODS: Whole...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486052/ https://www.ncbi.nlm.nih.gov/pubmed/36116213 http://dx.doi.org/10.1016/j.ebiom.2022.104267 |
_version_ | 1784792192420675584 |
---|---|
author | Xiao, Ruo-Wen Wang, Fang Wang, Tong-Min Zhang, Jiang-Bo Wu, Zi-Yi Deng, Chang-Mi Liao, Ying Zhou, Ting Yang, Da-Wei Dong, Si-Qi Xue, Wen-Qiong He, Yong-Qiao Zheng, Xiao-Hui Li, Xi-Zhao Zhang, Pei-Fen Zhang, Shao-Dan Hu, Ye-Zhu Liu, Yu-Ying Xia, Yun-Fei Gao, Song Mu, Jian-Bing Feng, Lin Jia, Wei-Hua |
author_facet | Xiao, Ruo-Wen Wang, Fang Wang, Tong-Min Zhang, Jiang-Bo Wu, Zi-Yi Deng, Chang-Mi Liao, Ying Zhou, Ting Yang, Da-Wei Dong, Si-Qi Xue, Wen-Qiong He, Yong-Qiao Zheng, Xiao-Hui Li, Xi-Zhao Zhang, Pei-Fen Zhang, Shao-Dan Hu, Ye-Zhu Liu, Yu-Ying Xia, Yun-Fei Gao, Song Mu, Jian-Bing Feng, Lin Jia, Wei-Hua |
author_sort | Xiao, Ruo-Wen |
collection | PubMed |
description | BACKGROUND: Nasopharyngeal carcinoma (NPC) exhibits significant familial aggregation; however, its susceptibility genes are largely unknown. Thus, this study aimed to identify germline mutations that might contribute to the risk of familial NPC, and explore their biological functions. METHODS: Whole-exome sequencing was performed in 13 NPC pedigrees with multiple cases. Mutations co-segregated with disease status were further validated in a cohort composed of 563 probands from independent families, 2,953 sporadic cases, and 3,175 healthy controls. Experimental studies were used to explore the functions of susceptibility genes and their disease-related mutations. FINDINGS: The three rare missense mutations in POLN (DNA polymerase nu) gene, P577L, R303Q, and F545C, were associated with familial NPC risk (5/576 [0·87%] in cases vs. 2/3374 [0·059%] in healthy controls with an adjusted OR of 44·84 [95% CI:3·91-514·34, p = 2·25 × 10(−3)]). POLN was involved in Epstein-Barr virus (EBV) lytic replication in NPC cells in vitro. POLN promoted viral DNA replication, immediate-early and late lytic gene expression, and progeny viral particle production, ultimately affecting the proliferation of host cells. The three mutations were located in two pivotal functional domains and were predicted to alter the protein stability of POLN in silico. Further assays demonstrated that POLN carrying any of the three mutations displayed reduced protein stability and decreased expression levels, thereby impairing its ability to promote complete EBV lytic replication and facilitate cell survival. INTERPRETATION: We identified a susceptibility gene POLN for familial NPC and elucidated its function. FUNDING: This study was funded by the National Key Research and Development Program of China (2021YFC2500400); the National Key Research and Development Program of China (2020YFC1316902); the Basic and Applied Basic Research Foundation of Guangdong Province, China (2021B1515420007); the National Natural Science Foundation of China (81973131); the National Natural Science Foundation of China (82003520); the National Natural Science Foundation of China (81903395). |
format | Online Article Text |
id | pubmed-9486052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94860522022-09-21 Rare POLN mutations confer risk for familial nasopharyngeal carcinoma through weakened Epstein-Barr virus lytic replication Xiao, Ruo-Wen Wang, Fang Wang, Tong-Min Zhang, Jiang-Bo Wu, Zi-Yi Deng, Chang-Mi Liao, Ying Zhou, Ting Yang, Da-Wei Dong, Si-Qi Xue, Wen-Qiong He, Yong-Qiao Zheng, Xiao-Hui Li, Xi-Zhao Zhang, Pei-Fen Zhang, Shao-Dan Hu, Ye-Zhu Liu, Yu-Ying Xia, Yun-Fei Gao, Song Mu, Jian-Bing Feng, Lin Jia, Wei-Hua eBioMedicine Articles BACKGROUND: Nasopharyngeal carcinoma (NPC) exhibits significant familial aggregation; however, its susceptibility genes are largely unknown. Thus, this study aimed to identify germline mutations that might contribute to the risk of familial NPC, and explore their biological functions. METHODS: Whole-exome sequencing was performed in 13 NPC pedigrees with multiple cases. Mutations co-segregated with disease status were further validated in a cohort composed of 563 probands from independent families, 2,953 sporadic cases, and 3,175 healthy controls. Experimental studies were used to explore the functions of susceptibility genes and their disease-related mutations. FINDINGS: The three rare missense mutations in POLN (DNA polymerase nu) gene, P577L, R303Q, and F545C, were associated with familial NPC risk (5/576 [0·87%] in cases vs. 2/3374 [0·059%] in healthy controls with an adjusted OR of 44·84 [95% CI:3·91-514·34, p = 2·25 × 10(−3)]). POLN was involved in Epstein-Barr virus (EBV) lytic replication in NPC cells in vitro. POLN promoted viral DNA replication, immediate-early and late lytic gene expression, and progeny viral particle production, ultimately affecting the proliferation of host cells. The three mutations were located in two pivotal functional domains and were predicted to alter the protein stability of POLN in silico. Further assays demonstrated that POLN carrying any of the three mutations displayed reduced protein stability and decreased expression levels, thereby impairing its ability to promote complete EBV lytic replication and facilitate cell survival. INTERPRETATION: We identified a susceptibility gene POLN for familial NPC and elucidated its function. FUNDING: This study was funded by the National Key Research and Development Program of China (2021YFC2500400); the National Key Research and Development Program of China (2020YFC1316902); the Basic and Applied Basic Research Foundation of Guangdong Province, China (2021B1515420007); the National Natural Science Foundation of China (81973131); the National Natural Science Foundation of China (82003520); the National Natural Science Foundation of China (81903395). Elsevier 2022-09-15 /pmc/articles/PMC9486052/ /pubmed/36116213 http://dx.doi.org/10.1016/j.ebiom.2022.104267 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Articles Xiao, Ruo-Wen Wang, Fang Wang, Tong-Min Zhang, Jiang-Bo Wu, Zi-Yi Deng, Chang-Mi Liao, Ying Zhou, Ting Yang, Da-Wei Dong, Si-Qi Xue, Wen-Qiong He, Yong-Qiao Zheng, Xiao-Hui Li, Xi-Zhao Zhang, Pei-Fen Zhang, Shao-Dan Hu, Ye-Zhu Liu, Yu-Ying Xia, Yun-Fei Gao, Song Mu, Jian-Bing Feng, Lin Jia, Wei-Hua Rare POLN mutations confer risk for familial nasopharyngeal carcinoma through weakened Epstein-Barr virus lytic replication |
title | Rare POLN mutations confer risk for familial nasopharyngeal carcinoma through weakened Epstein-Barr virus lytic replication |
title_full | Rare POLN mutations confer risk for familial nasopharyngeal carcinoma through weakened Epstein-Barr virus lytic replication |
title_fullStr | Rare POLN mutations confer risk for familial nasopharyngeal carcinoma through weakened Epstein-Barr virus lytic replication |
title_full_unstemmed | Rare POLN mutations confer risk for familial nasopharyngeal carcinoma through weakened Epstein-Barr virus lytic replication |
title_short | Rare POLN mutations confer risk for familial nasopharyngeal carcinoma through weakened Epstein-Barr virus lytic replication |
title_sort | rare poln mutations confer risk for familial nasopharyngeal carcinoma through weakened epstein-barr virus lytic replication |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486052/ https://www.ncbi.nlm.nih.gov/pubmed/36116213 http://dx.doi.org/10.1016/j.ebiom.2022.104267 |
work_keys_str_mv | AT xiaoruowen rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT wangfang rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT wangtongmin rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT zhangjiangbo rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT wuziyi rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT dengchangmi rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT liaoying rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT zhouting rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT yangdawei rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT dongsiqi rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT xuewenqiong rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT heyongqiao rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT zhengxiaohui rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT lixizhao rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT zhangpeifen rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT zhangshaodan rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT huyezhu rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT liuyuying rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT xiayunfei rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT gaosong rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT mujianbing rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT fenglin rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication AT jiaweihua rarepolnmutationsconferriskforfamilialnasopharyngealcarcinomathroughweakenedepsteinbarrviruslyticreplication |